Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 1 Interventional

Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris

ClinicalTrials.gov ID: NCT01182636

Public ClinicalTrials.gov record NCT01182636. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 27, 2026, 4:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Multiple-Site, Placebo Controlled, Parallel Design, Clinical Study to Evaluate the Bioequivalence of Adapalene Gel 0.1% (PLIVA Research & Development Ltd.) Compared to Differin® (Adapalene 0.1%) Topical Gel (Galderma Laboratories) in Patients With Acne Vulgaris

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The objective of this study was to evaluate the efficacy and safety of the test formulation of adapalene gel 0.1% (PLIVA Research \& Development Ltd.) as compared to the already marketed formulation, Differin® (adapalene 0.1%) topical gel (Galderma Laboratories) in patients with acne vulgaris.

Study identification

NCT ID
NCT01182636
Recruitment status
Completed
Study type
Interventional
Phase
Phase 1
Lead sponsor
Teva Pharmaceuticals USA
Industry
Enrollment
601 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
12 Years to 40 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 2007 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Nov 24, 2010

2007 – 2008

United States locations

U.S. sites
20
U.S. states
16
U.S. cities
18
Facility City State ZIP Site status
Dermatology Research of Arkansas Little Rock Arkansas 72205 —
Dermatology Research Associates Los Angeles California 90045 —
Cherry Creek Research, Inc. Denver Colorado 80209 —
University Clinical Research, Inc. Pembroke Pines Florida 33024 —
MedaPhase, Inc. Newnan Georgia 30263 —
SNBL Clinical Pharmacology Center, Inc. Baltimore Maryland 21201 —
Michigan Center for Research Corportation Clinton Township Michigan 48038 —
Office of Atoya Breona Adams, MD Las Vegas Nevada 89119 —
Academic Dermatology Associates Albuquerque New Mexico 87106 —
Helendale Dermatology & Medical Spa, LLC Rochester New York 14609 —
Dermatology Associates of Rochester, PC Rochester New York 14623 —
Office of Zoe Diana Draelos, MD High Point North Carolina 27262 —
University Dermatology Consultants, Inc. Cincinnati Ohio 45219 —
Novum Pharmaceutical Research Services Pittsburgh Pennsylvania 15206 —
Knoxville Dermatology, PC Knoxville Tennessee 37920 —
Arlington Center for Dermatology Arlington Texas 76011 —
Center for Clinical Studies Houston Texas 77030 —
Center for Clinical Studies Houston Texas 77058 —
Dermatology Associates of Tyler Tyler Texas 75701 —
Aurora Advanced Healthcare, Inc. Milwaukee Wisconsin 53209 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01182636, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 24, 2010 · Synced Oct 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01182636 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →